Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Antiaging Quantum Living (AAQL) EBITDA Margin (2020 - 2025)

Antiaging Quantum Living (AAQL) has disclosed EBITDA Margin for 6 consecutive years, with 73.18% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin fell 595.0% to 73.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 48.79% through Dec 2025, up 10050.0% year-over-year, with the annual reading at 87.65% for FY2025, 538459.0% up from the prior year.
  • EBITDA Margin hit 73.18% in Q4 2025 for Antiaging Quantum Living, down from 16.5% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 16.5% in Q3 2025 to a low of 2477.25% in Q2 2023.
  • Historically, EBITDA Margin has averaged 543.42% across 5 years, with a median of 169.3% in 2022.
  • Biggest five-year swings in EBITDA Margin: skyrocketed 481325bps in 2021 and later tumbled -159788bps in 2023.
  • Year by year, EBITDA Margin stood at 1379.29% in 2021, then skyrocketed by 88bps to 169.3% in 2022, then plummeted by -817bps to 1553.09% in 2023, then soared by 96bps to 67.23% in 2024, then fell by -9bps to 73.18% in 2025.
  • Business Quant data shows EBITDA Margin for AAQL at 73.18% in Q4 2025, 16.5% in Q3 2025, and 48.49% in Q2 2025.